Skip to main content
Jiangxi Sanxin Medtec Co.,Ltd. logo

Jiangxi Sanxin Medtec Co.,Ltd. — Investor Relations & Filings

Ticker · 300453 ISIN · CNE100001ZJ1 LEI · 836800E8MVDVV6772007 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,450 across all filing types
Latest filing 2026-05-20 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300453

About Jiangxi Sanxin Medtec Co.,Ltd.

https://www.sanxin-med.com

Jiangxi Sanxin Medtec Co.,Ltd. specializes in the research, development, manufacturing, and distribution of medical consumables and equipment. The company's primary product portfolio focuses on blood purification, including hemodialyzers, blood tubing sets, and dialysis concentrates. Additionally, it produces a wide range of sterile medical devices such as safety syringes, auto-disable syringes, venous catheters, and infusion sets. The organization emphasizes technological innovation and quality control, maintaining an integrated production chain for dialysis treatments. Its products are designed to meet international safety standards, serving healthcare providers in both domestic and global markets with a focus on infection prevention and patient care efficiency.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 98% confidence The document is a detailed announcement of the company’s 2025 annual equity distribution (cash dividend) scheme, specifying the dividend amount per share, total dividend sum, record date, ex-dividend date, payment arrangements, and related procedures. This matches the definition of a Notice of Dividend Amount (DIV).
2026-05-20 Chinese
江西三鑫医疗科技股份有限公司组织架构图（2026年5月）
Governance Information Classification · 90% confidence The document is simply an organizational structure chart (“组织架构图”) of the company dated May 2026, with no financial data, no report attachment notice, and no voting or transaction information. It outlines internal governance (board and management structure). Therefore, it fits the Governance Information category (CGR).
2026-05-19 Chinese
外汇套期保值业务管理制度（2026年5月）
Governance Information Classification · 95% confidence The document is a detailed internal policy/manual (“管理制度”) outlining the company’s foreign exchange hedging business management principles, approval procedures, risk controls, and disclosure requirements. It is not a financial report, earnings release, or transaction announcement, nor is it notifying of a meeting or vote. Rather, it sets out the company's governance rules and internal control framework for this business activity. This aligns with the definition of a Governance Information filing (CGR).
2026-05-19 Chinese
关于开展外汇套期保值业务的公告
Regulatory Filings Classification · 85% confidence The document is an exchange-listed company’s formal announcement about initiating a foreign exchange hedging program. It does not contain financial statements (so it is not a report like an interim or annual report), nor is it raising new capital or changing share capital (so not CAP or SHA). It’s a routine compliance disclosure to the exchange on hedging arrangements, which falls under the general regulatory announcements category. Therefore, the correct classification is RNS.
2026-05-19 Chinese
对外捐赠管理制度（2026年5月）
Governance Information Classification · 91% confidence The document is an internal policy outlining the company’s principles, procedures and approval authorities for external donations. It sets out governance rules rather than reporting financial results or announcing an event. This falls squarely under corporate governance information rather than an annual/interim report, earnings release, or regulatory announcement. Therefore, it is classified as Governance Information (CGR).
2026-05-19 Chinese
关于选举第六届董事会职工代表董事的公告
Board/Management Information Classification · 92% confidence The document is an official announcement by Jiangxi Sanxin Medical Technology Co., Ltd. regarding the election of an employee representative director to the company’s sixth Board of Directors. It outlines the election process, term of office, qualifications of the newly elected director, and related regulatory compliance. This clearly falls under announcements of changes in the company’s board of directors, which is categorized as Board/Management Information.
2026-05-14 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.